Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
Standard breast MRI studies often have lengthy protocols that make them inherently expensive
and time-consuming. Several studies of the use of abbreviated MRI protocols have shown that
the shorter protocols have diagnostic accuracy comparable to that of the conventional full
MRI protocol. There are also promising results of ultrafast DCE-MRI studies with shorter
breast MRI protocols that provide not only morphologic but also valuable kinetic information
about a lesion. The shorter imaging times achieved with the abbreviated and the ultrafast
DCE-MRI protocols have the potential to increase efficiency and lower cost by decreasing time
in the MRI suite, which in turn may make breast MRI accessible for population-based mass
screening. The focus of the proposed research is the investigation of an abbreviated MRI
protocol with ultrafast imaging using Dotarem® (Gadoterate Meglumine).